Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
1711
Lal UR, Tripathi SM, Jachak SM, Bhutani KK and Singh IP. Chemical changes during fermentation of Abhayarishta and its standardization by HPLC-DAD Natural Product Communications 2010, 5, 575-579.
1712
Lal UR, Tripathi SM, Jachak SM, Bhutani KK and Singh IP. RP-HPLC analysis of Jirakadyarishta and chemical changes during fermentation Natural Product Communications 2010, 5, 1767-1770.
1713
Madan J, Dhiman N, Parmar VK, Sardana S, Bharatam PV, Aneja R, Chandra R and Katyal A. Inclusion complexes of noscapine in ?-cyclodextrin offer better solubility and improved pharmacokinetics Cancer Chemotherapy and Pharmacology 2010, 65, 537-548.
1714
Malik S, Dixit VA, Bharatam PV and Kartha KPR. A simple, mild, and regioselective method for the benzylation of carbohydrate derivatives promoted by silver carbonate Carbohydrate Research 2010, 345, 559-564.
1715
Malik S, Shah KJ and Kartha KPR. Iodine-hexamethyldisilane (HMDS)-mediated anomerization of peracetylated 1,2-trans-linked alkyl and aryl glycosides Carbohydrate Research 2010, 345, 867-871.
1716
Mayatra SJ, Prasad B, Jain M, Jain R and Singh S. Development and validation of a sensitive and selective UHPLC-MS/MS method for quantitation of an investigational anti-malarial compound, 2-tert-butylprimaquine (NP-96) in rat plasma, and its application in a preclinical pharmacokinetic study Journal of Pharmaceutical and Biomedical Analysis 2010, 52, 410-415.
1717
Mehdi A, Adane L, Patel DS and Bharatam PV. Electronic structure and reactivity of guanylthiourea: A quantum chemical study Journal of Computational Chemistry 2010, 31, 1259-1267.
1718
Mehta S, Shah RP and Singh S. Strategy for identification and characterization of small quantities of drug degradation products using LC and LC-MS: Application to valsartan, a model drug Drug Testing and Analysis 2010, 2, 2173-2181.
1719
Mehta S, Shah RP, Priyadarshi R and Singh S. LC and LC-MS/TOF studies on stress degradation behaviour of candesartan cilexetil Journal of Pharmaceutical and Biomedical Analysis 2010, 52, 345-354.
1720
Mittal A, Negi P, Garkhal K, Verma S and Kumar N. Integration of porosity and bio-functionalization to form a 3D scaffold: cell culture studies and in vitro degradation Biomedical Materials 2010, 5, (doi: 10.1088/1748-6041/5/4/045001) .
1721
Moon LS, Pal M, Kasetti Y, Bharatam PV and Jolly RS. Chiral Solvating Agents for Cyanohydrins and Carboxylic acids Journal of Organic Chemistry 2010, 75, 5487-5498.
1722
Mughal A, Vikram A, Ramarao P and Jena GB. Micronucleus and comet assay in the peripheral blood of juvenile rat: Establishment of assay feasibility, time of sampling and the induction of DNA damage Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2010, 700, 86-94.
1723
Mugunthan G, Ramakrishna K and Kartha KPR. Trends in Carbohydrate Research 2010, 2, 20-27.
1724
Mulay SR, Gaikwad AB and Tikoo K. Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy Chemico-Biological Interactions 2010, 185, 137-142.
1725
Mungalpara J, Pandey A, Jain V and Mohan CG. Molecular modelling and QSAR analysis of some structurally diverse N-type calcium channel blockers Journal of Molecular Modeling 2010, 16, 629-644.
Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|115|15